- Home
- TXRH vs ASND Comparison
TXRH vs ASND Comparison
Compare TXRH & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TXRH
- ASND
- Stock Information
- Founded
- TXRH 1993
- ASND 2006
- Country
- TXRH United States
- ASND Denmark
- Employees
- TXRH N/A
- ASND N/A
- Industry
- TXRH Restaurants
- ASND Biotechnology: Pharmaceutical Preparations
- Sector
- TXRH Consumer Discretionary
- ASND Health Care
- Exchange
- TXRH Nasdaq
- ASND Nasdaq
- Market Cap
- TXRH 12.6B
- ASND 10.6B
- IPO Year
- TXRH 2004
- ASND 2015
- Fundamental
- Price
- TXRH $188.20
- ASND $175.45
- Analyst Decision
- TXRH Buy
- ASND Strong Buy
- Analyst Count
- TXRH 21
- ASND 17
- Target Price
- TXRH $192.52
- ASND $222.18
- AVG Volume (30 Days)
- TXRH 1.1M
- ASND 428.9K
- Earning Date
- TXRH 08-07-2025
- ASND 09-02-2025
- Dividend Yield
- TXRH 1.45%
- ASND N/A
- EPS Growth
- TXRH 30.91
- ASND N/A
- EPS
- TXRH 6.48
- ASND N/A
- Revenue
- TXRH $5,499,763,000.00
- ASND $398,509,511.00
- Revenue This Year
- TXRH $11.22
- ASND $77.19
- Revenue Next Year
- TXRH $8.90
- ASND $75.84
- P/E Ratio
- TXRH $29.03
- ASND N/A
- Revenue Growth
- TXRH 15.09
- ASND 12.06
- 52 Week Low
- TXRH $148.73
- ASND $111.09
- 52 Week High
- TXRH $206.04
- ASND $183.00
- Technical
- Relative Strength Index (RSI)
- TXRH 48.85
- ASND 54.14
- Support Level
- TXRH $184.72
- ASND $168.01
- Resistance Level
- TXRH $189.30
- ASND $180.00
- Average True Range (ATR)
- TXRH 4.11
- ASND 6.12
- MACD
- TXRH -0.46
- ASND -0.28
- Stochastic Oscillator
- TXRH 53.89
- ASND 59.33
About TXRH Texas Roadhouse Inc.
Texas Roadhouse Inc is a restaurant company operating predominantly in the casual dining segment. The company manages its restaurant and franchising operations by concept and, as a result, has identified Texas Roadhouse, Bubba's 33, Jaggers, and retail initiatives as separate operating segments. In addition, it has identified Texas Roadhouse and Bubba's 33 as reportable segments. Maximum revenue for the company is generated from the Texas Roadhouse segment, which is a moderately priced, full-service, casual dining restaurant concept offering steaks, a selection of ribs, seafood, chicken, pork chops, pulled pork, vegetable plates, and an assortment of hamburgers, salads, and sandwiches.
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.